Αποτελέσματα Αναζήτησης
Beryllium Copper SAFETY DATA SHEET 4 FIRST AID MEASURES General Measures: Under normal handling and use, exposure to solid forms of this material present few health hazards. Subsequent operations such as grinding, melting or welding may produce potentially hazardous dust or fumes which can be inhaled or come in contact with the skin or eyes.
Treatment of Chronic Beryllium Disease: There is no known treatment which will cure chronic beryllium disease. Prednisone or other corticosteroids are the most specific treatment currently available. They are directed at suppressing the immunological reaction and can be effective in diminishing signs and symptoms of chronic beryllium disease.
5 ημέρες πριν · Substances CAS No. / Substance Name: 7440-50-8 Copper Identification number(s): EC number: 231-159-6. 7440-41-7 Beryllium Identification number(s): EC number: 231-150-7 Index number: 004-001-00-7. SECTION 4. FIRST AID MEASURES. Description of first aid measures General information No special measures required. If inhaled: Seek medical treatment ...
INDICATIONS OF IMMEDIATE MEDICAL ATTENTION AND SPECIAL TREATMENT NEEDED, IF NECESSARY NOTES TO PHYSICIAN: Treat symptomatically. Contact poison treatment specialist immediately if large quantities have been ingested or inhaled. Airborne particles of beryllium alloys can, if inhaled to excess, cause irreversible lung damage in people who
16 Ιαν 2023 · Copper Beryllium Wrought Alloys Safety Data Sheet according to the Hazard Communication Standard (CFR29 1910.1200) HazCom 2012. Issue date: 1/16/2023 Revision date: 1/16/2023 Version: 1.0 1/16/2023 (Revision date) EN (English US) 1/12 SECTION 1: Identification 1.1. Identification Product form : Mixture
SAFETY DATA SHEET. Date Issued: March, 2018. Revisions of: FA1400 January 2003; April, 2015. 1. PRODUCT AND COMPANY IDENTIFICATION: Product Name: Beryllium C17000, C17200, C17500, C17510, CCNB Alloys. DISTRIBUTOR: Southern Copper & Supply Company, Inc.
19 Ιαν 2019 · Chronic beryllium disease is a condition that primarily affects the tissue of the lungs restricting the exchange of oxygen between the lungs and the bloodstream. The disease may manifest itself in various ways; nonproductive cough, fatigue
